Janux Therapeutics
JANX
JANX
180 hedge funds and large institutions have $1.81B invested in Janux Therapeutics in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 96 increasing their positions, 44 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
47% less capital invested
Capital invested by funds: $3.43B → $1.81B (-$1.63B)
64% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 53
Holders
180
Holding in Top 10
7
Calls
$17.2M
Puts
$4.35M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$22.2M | |
| 3 | +$18.6M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$10.8M |
Top Sellers
| 1 | -$54.3M | |
| 2 | -$27.6M | |
| 3 | -$17.7M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$16.2M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$13.6M |
